CVS Health (NYSE:CVS) Reaches New 1-Year Low at $54.04

CVS Health Co. (NYSE:CVS - Get Free Report) hit a new 52-week low during trading on Wednesday . The company traded as low as $54.04 and last traded at $55.45, with a volume of 10754423 shares. The stock had previously closed at $67.71.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. Barclays assumed coverage on shares of CVS Health in a report on Wednesday, March 6th. They set an "equal weight" rating and a $78.00 price target for the company. Leerink Partnrs reiterated an "outperform" rating on shares of CVS Health in a report on Monday, February 26th. Cantor Fitzgerald downgraded shares of CVS Health from an "overweight" rating to a "neutral" rating and lowered their price target for the stock from $87.00 to $58.00 in a report on Wednesday. Wells Fargo & Company lowered their price target on shares of CVS Health from $83.00 to $76.00 and set an "equal weight" rating for the company in a report on Monday, April 8th. Finally, StockNews.com downgraded shares of CVS Health from a "buy" rating to a "hold" rating in a report on Thursday, February 15th. Six research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat.com, CVS Health presently has an average rating of "Moderate Buy" and a consensus price target of $86.28.

CVS Health Trading Down 16.8 %

The company has a quick ratio of 0.63, a current ratio of 0.86 and a debt-to-equity ratio of 0.77. The firm's 50 day simple moving average is $74.05 and its 200-day simple moving average is $73.62. The company has a market capitalization of $70.98 billion, a PE ratio of 8.72, a P/E/G ratio of 0.89 and a beta of 0.52.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.01 by $0.11. CVS Health had a net margin of 2.33% and a return on equity of 15.25%. The company had revenue of $93.81 billion during the quarter, compared to the consensus estimate of $90.58 billion. During the same period in the previous year, the firm earned $1.99 earnings per share. CVS Health's revenue for the quarter was up 11.9% on a year-over-year basis. As a group, equities research analysts anticipate that CVS Health Co. will post 8.31 EPS for the current year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 1st. Stockholders of record on Monday, April 22nd will be given a dividend of $0.665 per share. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.72%. CVS Health's payout ratio is currently 41.18%.

Insider Transactions at CVS Health

In other news, EVP Prem S. Shah sold 29,473 shares of the business's stock in a transaction on Friday, February 16th. The shares were sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the transaction, the executive vice president now directly owns 39,765 shares of the company's stock, valued at $3,059,916.75. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Corporate insiders own 0.24% of the company's stock.

Institutional Trading of CVS Health

Several institutional investors have recently added to or reduced their stakes in CVS. Exchange Traded Concepts LLC raised its holdings in CVS Health by 22.8% in the third quarter. Exchange Traded Concepts LLC now owns 5,993 shares of the pharmacy operator's stock valued at $418,000 after acquiring an additional 1,112 shares in the last quarter. Brookstone Capital Management raised its holdings in CVS Health by 18.3% in the third quarter. Brookstone Capital Management now owns 60,115 shares of the pharmacy operator's stock valued at $4,245,000 after acquiring an additional 9,303 shares in the last quarter. Accurate Wealth Management LLC raised its holdings in CVS Health by 4.9% in the third quarter. Accurate Wealth Management LLC now owns 3,144 shares of the pharmacy operator's stock valued at $226,000 after acquiring an additional 148 shares in the last quarter. Xponance Inc. raised its holdings in CVS Health by 2.7% in the third quarter. Xponance Inc. now owns 176,052 shares of the pharmacy operator's stock valued at $12,292,000 after acquiring an additional 4,599 shares in the last quarter. Finally, Pinnacle Associates Ltd. increased its stake in CVS Health by 24.7% during the third quarter. Pinnacle Associates Ltd. now owns 167,903 shares of the pharmacy operator's stock valued at $11,723,000 after purchasing an additional 33,274 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.